BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28004523)

  • 1. Accuracy of self-report of HIV viral load among people with HIV on antiretroviral treatment.
    Sewell J; Daskalopoulou M; Nakagawa F; Lampe FC; Edwards S; Perry N; Wilkins E; O'Connell R; Jones M; Collins S; Speakman A; Phillips AN; Rodger AJ;
    HIV Med; 2017 Aug; 18(7):463-473. PubMed ID: 28004523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Disclosure of HIV Status and Associations with Psychological Factors, ART Non-Adherence, and Viral Load Non-Suppression Among People Living with HIV in the UK.
    Daskalopoulou M; Lampe FC; Sherr L; Phillips AN; Johnson MA; Gilson R; Perry N; Wilkins E; Lascar M; Collins S; Hart G; Speakman A; Rodger AJ;
    AIDS Behav; 2017 Jan; 21(1):184-195. PubMed ID: 27586375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual behaviour among people with HIV according to self-reported antiretroviral treatment and viral load status.
    Lampe FC;
    AIDS; 2016 Jul; 30(11):1745-59. PubMed ID: 27045375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community viral load and CD4 count distribution among people living with HIV in a South African Township: implications for treatment as prevention.
    Kranzer K; Lawn SD; Johnson LF; Bekker LG; Wood R
    J Acquir Immune Defic Syndr; 2013 Aug; 63(4):498-505. PubMed ID: 23572010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discordance of Self-report and Laboratory Measures of HIV Viral Load Among Young Men Who Have Sex with Men and Transgender Women in Chicago: Implications for Epidemiology, Care, and Prevention.
    Mustanski B; Ryan DT; Remble TA; D'Aquila RT; Newcomb ME; Morgan E
    AIDS Behav; 2018 Jul; 22(7):2360-2367. PubMed ID: 29637386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trial.
    Butler K; Inshaw J; Ford D; Bernays S; Scott K; Kenny J; Klein N; Turkova A; Harper L; Nastouli E; Paparini S; Choudhury R; Rhodes T; Babiker A; Gibb D
    Health Technol Assess; 2016 Jun; 20(49):1-108. PubMed ID: 27377073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of opportunistic illness on HIV RNA viral load and CD4+ T cell count among HIV-positive adults taking antiretroviral therapy.
    Ekwaru JP; Campbell J; Malamba S; Moore DM; Were W; Mermin J
    J Int AIDS Soc; 2013 Apr; 16(1):17355. PubMed ID: 23547778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-reported antiretroviral therapy adherence and viral load in criminal justice-involved populations.
    Cunningham WE; Nance RM; Golin CE; Flynn P; Knight K; Beckwith CG; Kuo I; Spaulding A; Taxman FS; Altice F; Delaney JA; Crane HM; Springer SA
    BMC Infect Dis; 2019 Oct; 19(1):913. PubMed ID: 31664910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with recent unsuppressed viral load in HIV-1-infected patients in care on first-line antiretroviral therapy in South Africa.
    Joseph Davey D; Abrahams Z; Feinberg M; Prins M; Serrao C; Medeossi B; Darkoh E
    Int J STD AIDS; 2018 May; 29(6):603-610. PubMed ID: 29334886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. British HIV Association (BHIVA) national cohort outcomes audit of patients commencing antiretrovirals from naïve.
    Street E; Curtis H; Sabin CA; Monteiro EF; Johnson MA;
    HIV Med; 2009 Jul; 10(6):337-42. PubMed ID: 19490183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in CD4 and viral load testing 2005 to 2018: multi-cohort study of people living with HIV in Southern Africa.
    Zaniewski E; Dao Ostinelli CH; Chammartin F; Maxwell N; Davies MA; Euvrard J; van Dijk J; Bosomprah S; Phiri S; Tanser F; Sipambo N; Muhairwe J; Fatti G; Prozesky H; Wood R; Ford N; Fox MP; Egger M
    J Int AIDS Soc; 2020 Jul; 23(7):e25546. PubMed ID: 32640106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suboptimal immune recovery and associated factors among people living with HIV/AIDS on second-line antiretroviral therapy in central China: A retrospective cohort study.
    Zhu K; Xu Q; Ma Y; Li P; Jia H; Jiang Q; Wang Y; Wu Z; Wang D; Guo H; Jin Y
    J Med Virol; 2022 Oct; 94(10):4975-4982. PubMed ID: 35710693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethnicity and discordance in plasma HIV-1 RNA viral load and CD4+ lymphocyte count in a cohort of HIV-1-infected individuals.
    Smith PR; Sarner L; Murphy M; James B; Thomas JM; Skinner CJ; Aitken C
    J Clin Virol; 2003 Jan; 26(1):101-7. PubMed ID: 12589840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.
    May MT; Gompels M; Delpech V; Porter K; Orkin C; Kegg S; Hay P; Johnson M; Palfreeman A; Gilson R; Chadwick D; Martin F; Hill T; Walsh J; Post F; Fisher M; Ainsworth J; Jose S; Leen C; Nelson M; Anderson J; Sabin C;
    AIDS; 2014 May; 28(8):1193-202. PubMed ID: 24556869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low detectable postpartum viral load is associated with HIV transmission in Malawi's prevention of mother-to-child transmission programme.
    Landes M; van Lettow M; Nkhoma E; Tippett Barr B; Truwah Z; Shouten E; Jahn A; Auld A; Kalua T; van Oosterhout JJ
    J Int AIDS Soc; 2019 Jun; 22(6):e25290. PubMed ID: 31180186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/μl in rural Uganda.
    Jain V; Byonanebye DM; Amanyire G; Kwarisiima D; Black D; Kabami J; Chamie G; Clark TD; Rooney JF; Charlebois ED; Kamya MR; Havlir DV;
    AIDS; 2014 Sep; 28(15):2241-9. PubMed ID: 25022596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
    Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
    J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma.
    Soulie C; Grudé M; Descamps D; Amiel C; Morand-Joubert L; Raymond S; Pallier C; Bellecave P; Reigadas S; Trabaud MA; Delaugerre C; Montes B; Barin F; Ferré V; Jeulin H; Alloui C; Yerly S; Signori-Schmuck A; Guigon A; Fafi-Kremer S; Haïm-Boukobza S; Mirand A; Maillard A; Vallet S; Roussel C; Assoumou L; Calvez V; Flandre P; Marcelin AG;
    J Antimicrob Chemother; 2017 Aug; 72(8):2351-2354. PubMed ID: 28472307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication.
    Alatrakchi N; Duvivier C; Costagliola D; Samri A; Marcelin AG; Kamkamidze G; Astriti M; Agher R; Calvez V; Autran B; Katlama C
    AIDS; 2005 Jan; 19(1):25-33. PubMed ID: 15627030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China.
    Liu P; You Y; Liao L; Feng Y; Shao Y; Xing H; Lan G; Li J; Ruan Y; Li D
    BMC Infect Dis; 2022 May; 22(1):426. PubMed ID: 35509014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.